Interestingly, we observed that only the CD3+ T lymphocytes derived from zebularine-treated mice inhibited tumor growth (Fig. 3g, h and Supplementary Fig. 3f and Supplementary Fig. 3g), whereas adoptive therapy with CD4+ or CD8+ T cells alone did not delay tumor growth (Fig. 3i, j). The gene discussed is CD8A; the disease is neoplasm.